Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
Ropeginterferon alfa-2b is a novel mono-pegylated and extra-long-acting interferon, being developed for the treatment of myeloproliferative neoplasm (MPN) and chronic viral hepatitis. It has a favorable pharmacokinetic profile and less frequent dosing schedule, i.e., once every two to four weeks, co...
| Những tác giả chính: | , , , |
|---|---|
| Định dạng: | Bài viết |
| Ngôn ngữ: | English |
| Được phát hành: |
MDPI AG
2022-05-01
|
| Loạt: | Viruses |
| Những chủ đề: | |
| Truy cập trực tuyến: | https://www.mdpi.com/1999-4915/14/6/1128 |